GenMark Files for Public Offering | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GenMark Diagnostics today filed a document with the US Securities and Exchange Commission for an offering of its common stock to raise in aggregate a maximum of about $28.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.